Fudan University
🇨🇳China
- Country
- 🇨🇳China
- Ownership
- Private
- Established
- 1905-01-01
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.fudan.edu.cn
Esophagectomy: Sweet Versus Ivor-Lewis (ESVIL) (ECTOP-2001)
Not Applicable
Completed
- Conditions
- Esophageal Neoplasms
- Interventions
- Procedure: Esophagectomy
- First Posted Date
- 2010-01-12
- Last Posted Date
- 2023-07-20
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 300
- Registration Number
- NCT01047111
- Locations
- 🇨🇳
Fudan University Cancer Center, Shanghai, Shanghai, China
Efficacy of Postoperative Adjuvant Treatments for Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis
Not Applicable
- Conditions
- Hepatocellular Carcinoma
- Interventions
- Other: PVIC, TACE
- First Posted Date
- 2009-12-16
- Last Posted Date
- 2009-12-16
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 260
- Registration Number
- NCT01033578
- Locations
- 🇨🇳
Liver Cancer Insitute, Zhongshan Hospital, Shanghai, China
A Randomized Trial Comparing EC-wPversus EP-wP as Adjuvant Therapy for Operable Breast Cancer Patients Less Than 40 Years Old
Phase 3
Completed
- Conditions
- Breast Neoplasms
- Interventions
- First Posted Date
- 2009-12-04
- Last Posted Date
- 2020-05-12
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 521
- Registration Number
- NCT01026116
- Locations
- 🇨🇳
Department of Breast Surgery, Cancer Hospital, Fudan University, Shanghai, China
Safety Study of Sorafenib Following Combined Therapy of Radiation and TACE for Liver Cancer
Phase 1
- Conditions
- Hepatocellular Carcinoma
- First Posted Date
- 2009-10-22
- Last Posted Date
- 2009-10-22
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 30
- Registration Number
- NCT00999843
- Locations
- 🇨🇳
Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China
Randomized Controlled Trials on Adjuvant Intraperitoneal Chemotherapy for Resectable Local Advanced Gastric Cancer
Phase 2
- Conditions
- Advanced Gastric Cancer
- Interventions
- Drug: cisplatin, Fluorouracil
- First Posted Date
- 2009-10-09
- Last Posted Date
- 2010-09-08
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 79
- Registration Number
- NCT00992199
- Locations
- 🇨🇳
Fudan University Cancer Hospital, Shanghai, Shanghai, China
Endostar Combined With CHOP Regimen as First Line Chemotherapy for Peripheral T Cell Lymphoma
- First Posted Date
- 2009-09-10
- Last Posted Date
- 2010-09-15
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 15
- Registration Number
- NCT00974324
- Locations
- 🇨🇳
Fudan University Cancer Hospital, Shanghai, Shanghai, China
Apatinib Versus Placebo as a Third Line Treatment in Patients With Advanced or Metastatic Gastric Cancer
- First Posted Date
- 2009-09-02
- Last Posted Date
- 2011-07-12
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 141
- Registration Number
- NCT00970138
- Locations
- 🇨🇳
Fudan University Cancer Hospital, ShangHai, Shanghai, China
Dexrazoxane as a Protective Agent in Anthracycline Treated Breast Cancer
- First Posted Date
- 2009-08-10
- Last Posted Date
- 2012-02-28
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 12
- Registration Number
- NCT00955890
- Locations
- 🇨🇳
Fudan University Cancer Hospital, Shanghai, Shanghai, China
Computed Tomography (CT) Based Lymphatic Mapping and Localization of Sentinel Lymph Node in Breast Cancer Patients
Phase 3
- Conditions
- Breast Cancer
- Interventions
- Device: Breast Lesion Localization Needles (interv)
- First Posted Date
- 2009-08-06
- Last Posted Date
- 2009-08-06
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 50
- Registration Number
- NCT00952679
- Locations
- 🇨🇳
Cancer hospital, Shanghai, Shanghai, China
New Combination Regimen of L-asparaginase, Dexamethasone, Ifosfamide, Cisplatin and Etoposide in NK/T-Cell Lymphoma
Phase 2
- Conditions
- Lymphoma
- Interventions
- Drug: L-asp, DXM, IFO, VP-16, DDP
- First Posted Date
- 2009-07-07
- Last Posted Date
- 2012-02-20
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 76
- Registration Number
- NCT00933673
- Locations
- 🇨🇳
Fudan University Cancer Hospital, Shanghai, Shanghai, China
© Copyright 2025. All Rights Reserved by MedPath